PureHelix™ Genomic Prep Kit [Bacteria] (Solution based)
- Known as:
- PureHelix™ Genomic Prep Kit [Bacteria] (Solution based)
- Catalog number:
- GSBA400
- Product Quantity:
- 400 preps/kit
- Category:
- -
- Supplier:
- NanoHelix
- Gene target:
- PureHelix™ Genomic Prep Kit [Bacteria] (Solution based)
Related genes to: PureHelix™ Genomic Prep Kit [Bacteria] (Solution based)
- Gene:
- PREP NIH gene
- Name:
- prolyl endopeptidase
- Previous symbol:
- -
- Synonyms:
- -
- Chromosome:
- 6q21
- Locus Type:
- gene with protein product
- Date approved:
- 1996-03-12
- Date modifiied:
- 2016-10-05
Related products to: PureHelix™ Genomic Prep Kit [Bacteria] (Solution based)
Human ELC ELISA KIT 96 TEST
OxiSelect In Vitro ROS/RNS Assay Kit (Green Fluorescence), Trial Size
OxiSelect Methylglyoxal (MG) Competitive ELISA Kit
OxiSelect Methylglyoxal (MG) Competitive ELISA Kit
OxiSelect TBARS Assay Kit (MDA Quantitation), Trial Size
OxiSelect Total Antioxidant Capacity (TAC) Assay Kit, Trial Size
OxiSelect™ In Vitro ROS RNS Assay Kit (Green Fluorescence), Trial Size(+)_1_(9_Fluorenyl)ethyl chloroformate 0.5 w_v% solution in ac(1-Kit )11,12-EET DHET Immunoassay Kit(1-Kit )11,12-EET_DHET Immunoassay Kit(1-Kit) 11,12-DHET Immunoassay Kit(1-Kit) 14,15-DHET Human Urine ELISA Kit(1-Kit) 14,15-DHET Hypertension ELISA Kit(1-Kit) 14,15-DHET sEH activity ELISA Kit(1-Kit) 14,15-EET DHET Hypertension ELISA Kit Related articles to: PureHelix™ Genomic Prep Kit [Bacteria] (Solution based)
- Transgender individuals face disproportionate HIV burden yet experience significant barriers to accessing biomedical HIV prevention. We assessed awareness, experience, and willingness among trans adults to use pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) when integrated with telehealth-delivered gender-affirming hormone care (GAC). - Source: PubMed
Publication date: 2026/08/27
Aitcheson NancyLi YunFeng YixuanO'Brien Caroline SKyweluk MoiraDowshen NadiaMomplaisir Florence - Depression and suicidal ideation are common among men who have sex with men (MSM) and transgender women (TGW). Pre-exposure prophylaxis (PrEP) has become an important component of HIV prevention, but its relationship with mental health remains incompletely understood. This study compared depression and suicidal ideation/risk between PrEP users and non-users among MSM and TGW attending HIV prevention services, and identified factors associated with depression. - Source: PubMed
Publication date: 2026/09/15
Lynn Kyaw SeinAurpibul LindaChotirosniramit NuntisaKosashunhanan NatthapolSrithanaviboonchai KriengkraiOon-Arom Awirut - People who inject drugs (PWID), who are disproportionately affected by HIV and HCV, also face structural barriers to antiretroviral therapy (ART), pre-exposure prophylaxis (PrEP), and HCV treatment and prevention retention. Global positioning system (GPS) devices may help locate them and support their navigation through healthcare and social services. - Source: PubMed
Publication date: 2026/09/18
Suprasert BowRuiz RaulLella PaavaniO'Neal Iris RVelasquez GueslynBaguso Glenda NWilson Erin CMcFarland WilliSheira Lila A - Human immunodeficiency virus (HIV) remains an important public health concern within the U.S. Armed Forces and a potential threat to force health protection and operational readiness. Within the Military Health System, a key problem is inconsistent engagement with HIV prevention services among at-risk service members despite mandated screening and universal access to pre-exposure prophylaxis (PrEP). Structural stigma, confidentiality concerns, and perceived career consequences may discourage participation in HIV prevention services, particularly when interventions rely on disclosure of sensitive behaviors during clinical encounters. Digital health strategies may provide confidential pathways for service members to assess personal risk and access prevention resources outside traditional clinical settings. This quality improvement initiative evaluated the feasibility and early system-level impact of implementing a confidential, QR-enabled mobile HIV risk self-assessment designed to increase engagement with preventive services, including HIV testing and PrEP. - Source: PubMed
Publication date: 2026/09/18
Nucup Dominica MRoque Autumn - HIV treatment attitudes and HIV PrEP are associated with sexual behavior that elevates the risk for bacterial STIs (B-STIs) among gay, bisexual and other men who have sex with men (GBM). Using a longitudinal multi-site study (Engage Cohort Study, 2017-2024), we modelled direct and indirect within- and between-person effects of HIV treatment attitudes and PrEP use on condomless anal sex (CAS) and incident B-STIs among 1863 HIV-negative GBM. We modelled up to four years of follow-up visits using multi-level mediation analysis, with CAS as a mediating variable between HIV treatment attitudes and PrEP use on incident B-STIs. We found direct within-person effects of HIV treatment attitudes and PrEP use on incident B-STIs, such that participants were more likely to report incident B-STIs at time points if they reported using PrEP and being more optimistic about HIV treatments; there were no indirect within-person effects through CAS. In contrast, we found both direct and indirect between-person effects. Specifically, participants who reported more PrEP use or who were more optimistic about HIV treatments over the course of the study were more likely to report incident B-STIs. Further, these effects were partially mediated by CAS. Given that we found within-person PrEP use is associated with increased CAS and STIs, and the general increase in adoption of PrEP over time, there is a need to expand biomedical intervention programs for B-STIs prophylaxis by integrating them with social and informational interventions about B-STIs risks, especially for GBM who use HIV PrEP. - Source: PubMed
Publication date: 2026/09/18
Hart Trevor APalma Paolo ADeng YangqingNoor Syed WMoore DavidZhang TerriGrace DanielLachowsky Nathan JCox JosephSkakoon-Sparling ShaynaGormezano AkiDvorakova MiladaLal AllanJollimore JodyTan Darrell H S